New hope for HIV patients: study targets smoking and drinking together
NCT ID NCT06790342
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study looks at whether adding a medication called cytisine to intensive counseling helps people with HIV in Kenya quit smoking and stop heavy drinking. About 300 participants will be followed to see if they can stay smoke-free and avoid heavy alcohol use. The goal is to improve overall health in a resource-limited setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mathari National Teaching and Referral Hospital
Nairobi, Kenya
-
Riruta Health Centre
Nairobi, Kenya
Conditions
Explore the condition pages connected to this study.